Clinical Trial Update: Efficacy of Galantamine to Treat Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing galantamine for schizophrenia has been terminated, with no efficacy results reported in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorder
• Schizophrenia

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: Seattle Institute for Biomedical and Clinical Research | Conditions: Schizophrenia, Psychotic Disorder | Phase 4 | Status: TERMINATED